Ghent Doctor: Antibiotics Not Standard for Urinary Infections as Resistant Cases Rise

Antibiotics should no longer be the default treatment for simple urinary tract infections, according to a Ghent hospital physician who warns that resistant infections are already reaching her wards routinely — and that 25 to 50 percent of these infections resolve without any antibiotic at all.

Her warning follows what she encounters on her own rounds: patients with relatively straightforward infections caused by bacteria against which, in her words, "hardly or no treatment is available anymore."

“We are now regularly confronted as doctors in Belgium with a patient with an infection caused by a bacterium against which hardly or no treatment is still available,” she said. “These are relatively simple infections, but we no longer have a solution for them. I try to do everything to get them through it anyway. But if this continues, we will get into trouble.”

The stakes she attaches to the message are global. She cites a figure of 4.71 million deaths worldwide related to antibiotic resistance, and calls resistance “one of the greatest threats to global health” — while noting that public alertness remains low precisely because the trend unfolds slowly, unlike an acute epidemic such as COVID-19.

Clearing infections without antibiotics

  • Most uncomplicated urinary tract infections in otherwise healthy people can clear on their own, or with an anti-inflammatory painkiller and plenty of fluids — not antibiotics.
  • A “delayed prescription” is an option worth asking about: a prescription that only becomes valid after, for example, two days if symptoms have not improved.
  • Every unnecessary course of antibiotics pushes bacteria one step closer to becoming untreatable — a process that cannot be reversed for the individual patient once it happens.

Why urinary tract infections carry the antibiotic load

Public health campaigns have long focused on respiratory infections, where antibiotics are usually unnecessary. Huis in ‘t Veld says the second-largest consumer of antibiotics — after respiratory infections — is the treatment of urinary tract infections, and that this category deserves the same critical scrutiny.

The numbers she cites make the case. Urinary tract infections account for nearly one in five of all antibiotic prescriptions. In 57 percent of all urinary tract infection cases, antibiotics are the chosen treatment — while studies show that in 25 to 50 percent of cases, these infections heal spontaneously, and in two-thirds of cases, anti-inflammatory medication is sufficient.

For people who are otherwise healthy, the official advice, as she relays it, is simple: drink plenty of fluids and, if needed, take a painkiller. “Our body can solve a great deal by itself, even when it is a bacterial infection,” she said.

Measure Share of urinary tract infection cases
Antibiotics chosen as treatment 57%
Infections that resolve spontaneously without antibiotics 25–50%
Cases where anti-inflammatories suffice About two-thirds
Share of all antibiotic prescriptions accounted for by urinary tract infections Nearly one in five

The mechanism behind the warning

Antibiotic resistance works through natural selection at microscopic scale. When an antibiotic kills susceptible bacteria but leaves behind the few cells that happen to carry protective mutations, those survivors multiply. Repeat that cycle across millions of prescriptions, and the bacterial population in a community gradually shifts toward strains that common drugs can no longer touch.

That is what Huis in ‘t Veld says she now sees clinically: not a rare worst case, but a recurring pattern. “We see now, regularly, someone with an infection caused by a resistant bacterium,” she said. The clinical consequence is that physicians resort to last-line drugs that are more expensive, carry more side effects, and may themselves eventually fail.

What changes for patients and prescribers

Together with her colleagues from the Ziekenhuisnetwerk Gent, Huis in ‘t Veld wants to prompt other physicians to think more carefully before prescribing. The practical shift she proposes is not a ban but a reordering of defaults: watchful waiting, symptom relief, and a delayed prescription as the starting point for uncomplicated cases, with antibiotics reserved for situations where they are genuinely needed.

“Of course, in a number of cases antibiotics are certainly still needed,” she said. The point is proportionality — matching the strength of the intervention to the clinical picture rather than reaching for the prescription pad reflexively.

She extends the appeal to patients as well. People who experience recurrent urinary tract infections often come to regard antibiotics as the standard treatment, she observes, and they too are entitled to ask their doctor whether antibiotics are actually necessary in a given episode.

Accumulating resistance demands attention

Part of the challenge, as Huis in ‘t Veld frames it, is temporal. Resistance does not arrive as a sudden wave with a visible peak; it accumulates. “It is not an acute epidemic like COVID, but we really need to pay more attention to it,” she said. In some countries, she adds, mortality figures for certain forms of cancer are now lower than the toll from resistant infections.

That framing places Belgium’s hospital networks within a global pattern: antimicrobial resistance is recognized internationally as one of the leading threats to global health, and the 4.71 million annual deaths she cites reflect deaths associated with resistant infections worldwide — a burden that grows with every avoidable prescription.

Consult a doctor for infections

The advice to wait and treat symptoms applies, as the source states, to people who are otherwise healthy with an uncomplicated urinary tract infection.

The trajectory from here

The gap she identifies — 57 percent of urinary tract infections treated with antibiotics versus a spontaneous resolution rate of up to half — is the space in which resistance either slows or accelerates.

“Resistance to antibiotics is one of the greatest threats to global health,” she said. “But the alertness for it is low, because the evolution goes relatively slowly.”

References

  • Huis in ‘t Veld, D., interview on antimicrobial stewardship and urinary tract infections.
  • Global burden figure of 4.71 million deaths related to antibiotic resistance, as cited by Dr. Diana Huis in ‘t Veld.

Readers should consult a qualified healthcare professional regarding any symptoms or treatment decisions.

Photo of author

Health Desk

Health Desk at Archyde.

Kucherov Would Consider Signing with Canadiens if Offer is Competitive, Says Pagnotta

Swiss Arms Vote Threatens EU Defense Pact, 150B Euro Fund